BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 25283840)

  • 1. The Krüppel-like factor 2 transcription factor gene is recurrently mutated in splenic marginal zone lymphoma.
    Piva R; Deaglio S; Famà R; Buonincontri R; Scarfò I; Bruscaggin A; Mereu E; Serra S; Spina V; Brusa D; Garaffo G; Monti S; Dal Bo M; Marasca R; Arcaini L; Neri A; Gattei V; Paulli M; Tiacci E; Bertoni F; Pileri SA; Foà R; Inghirami G; Gaidano G; Rossi D
    Leukemia; 2015 Feb; 29(2):503-7. PubMed ID: 25283840
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical and diagnostic relevance of
    Campos-Martín Y; Martínez N; Martínez-López A; Cereceda L; Casado F; Algara P; Oscier D; Menarguez FJ; García JF; Piris MA; Mollejo M
    Haematologica; 2017 Aug; 102(8):e310-e312. PubMed ID: 28522570
    [No Abstract]   [Full Text] [Related]  

  • 3. KLF2 mutation is the most frequent somatic change in splenic marginal zone lymphoma and identifies a subset with distinct genotype.
    Clipson A; Wang M; de Leval L; Ashton-Key M; Wotherspoon A; Vassiliou G; Bolli N; Grove C; Moody S; Escudero-Ibarz L; Gundem G; Brugger K; Xue X; Mi E; Bench A; Scott M; Liu H; Follows G; Robles EF; Martinez-Climent JA; Oscier D; Watkins AJ; Du MQ
    Leukemia; 2015 May; 29(5):1177-85. PubMed ID: 25428260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevalence of IG translocations and 7q32 deletions in splenic marginal zone lymphoma.
    Remstein ED; Law M; Mollejo M; Piris MA; Kurtin PJ; Dogan A
    Leukemia; 2008 Jun; 22(6):1268-72. PubMed ID: 17989713
    [No Abstract]   [Full Text] [Related]  

  • 5. NF-κB deregulation in splenic marginal zone lymphoma.
    Spina V; Rossi D
    Semin Cancer Biol; 2016 Aug; 39():61-7. PubMed ID: 27503810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetics and Prognostication in Splenic Marginal Zone Lymphoma: Revelations from Deep Sequencing.
    Parry M; Rose-Zerilli MJ; Ljungström V; Gibson J; Wang J; Walewska R; Parker H; Parker A; Davis Z; Gardiner A; McIver-Brown N; Kalpadakis C; Xochelli A; Anagnostopoulos A; Fazi C; de Castro DG; Dearden C; Pratt G; Rosenquist R; Ashton-Key M; Forconi F; Collins A; Ghia P; Matutes E; Pangalis G; Stamatopoulos K; Oscier D; Strefford JC
    Clin Cancer Res; 2015 Sep; 21(18):4174-4183. PubMed ID: 25779943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Splenic marginal zone lymphoma.
    Piris MA; Onaindía A; Mollejo M
    Best Pract Res Clin Haematol; 2017; 30(1-2):56-64. PubMed ID: 28288718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Splenic marginal zone lymphoma: from genetics to management.
    Arcaini L; Rossi D; Paulli M
    Blood; 2016 Apr; 127(17):2072-81. PubMed ID: 26989207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Splenic marginal zone lymphoma: characterization of 7q deletion and its value in diagnosis.
    Watkins AJ; Huang Y; Ye H; Chanudet E; Johnson N; Hamoudi R; Liu H; Dong G; Attygalle A; McPhail ED; Law ME; Isaacson PG; de Leval L; Wotherspoon A; Du MQ
    J Pathol; 2010 Mar; 220(4):461-74. PubMed ID: 20077527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exome sequencing identifies recurrent
    Jallades L; Baseggio L; Sujobert P; Huet S; Chabane K; Callet-Bauchu E; Verney A; Hayette S; Desvignes JP; Salgado D; Levy N; Béroud C; Felman P; Berger F; Magaud JP; Genestier L; Salles G; Traverse-Glehen A
    Haematologica; 2017 Oct; 102(10):1758-1766. PubMed ID: 28751561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Splenic B-cell lymphomas with more than 55% prolymphocytes in blood: evidence for prolymphocytoid transformation.
    Hoehn D; Miranda RN; Kanagal-Shamanna R; Lin P; Medeiros LJ
    Hum Pathol; 2012 Nov; 43(11):1828-38. PubMed ID: 22520947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translocation t(9;14)(p13;q32) in cases of splenic marginal zone lymphoma.
    Baró C; Salido M; Domingo A; Granada I; Colomo L; Serrano S; Solé F
    Haematologica; 2006 Sep; 91(9):1289-91. PubMed ID: 16956840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FOXP1 status in splenic marginal zone lymphoma: a fluorescence in situ hybridization and immunohistochemistry approach.
    Baró C; Espinet B; Salido M; Colomo L; Luño E; Florensa L; Ferrer A; Salar A; Campo E; Serrano S; Solé F
    Histol Histopathol; 2009 Nov; 24(11):1399-404. PubMed ID: 19760589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BCR and TLR signaling pathways are recurrently targeted by genetic changes in splenic marginal zone lymphomas.
    Yan Q; Huang Y; Watkins AJ; Kocialkowski S; Zeng N; Hamoudi RA; Isaacson PG; de Leval L; Wotherspoon A; Du MQ
    Haematologica; 2012 Apr; 97(4):595-8. PubMed ID: 22102703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole exome sequencing identifies novel recurrently mutated genes in patients with splenic marginal zone lymphoma.
    Parry M; Rose-Zerilli MJ; Gibson J; Ennis S; Walewska R; Forster J; Parker H; Davis Z; Gardiner A; Collins A; Oscier DG; Strefford JC
    PLoS One; 2013; 8(12):e83244. PubMed ID: 24349473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole exome sequencing of microdissected splenic marginal zone lymphoma: a study to discover novel tumor-specific mutations.
    Peveling-Oberhag J; Wolters F; Döring C; Walter D; Sellmann L; Scholtysik R; Lucioni M; Schubach M; Paulli M; Biskup S; Zeuzem S; Küppers R; Hansmann ML
    BMC Cancer; 2015 Oct; 15():773. PubMed ID: 26498442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of CD95/FAS gene somatic mutations in extranodal, nodal and splenic marginal zone B cell lymphomas.
    Bertoni F; Conconi A; Luminari S; Realini C; Roggero E; Baldini L; Carobbio S; Cavalli F; Neri A; Zucca E
    Leukemia; 2000 Mar; 14(3):446-8. PubMed ID: 10720140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenetics features and genomic lesions in splenic marginal zone lymphoma.
    Rinaldi A; Forconi F; Arcaini L; Mian M; Sozzi E; Zibellini S; Baldini L; Franceschetti S; Gaidano G; Marasca R; Mollejo M; Piris MA; Tucci A; Facchetti F; Bhagat G; Favera RD; Rancoita PM; Zucca E; Kwee I; Bertoni F
    Br J Haematol; 2010 Dec; 151(5):435-9. PubMed ID: 21113978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA methylation profiling identifies two splenic marginal zone lymphoma subgroups with different clinical and genetic features.
    Arribas AJ; Rinaldi A; Mensah AA; Kwee I; Cascione L; Robles EF; Martinez-Climent JA; Oscier D; Arcaini L; Baldini L; Marasca R; Thieblemont C; Briere J; Forconi F; Zamò A; Bonifacio M; Mollejo M; Facchetti F; Dirnhofer S; Ponzoni M; Bhagat G; Piris MA; Gaidano G; Zucca E; Rossi D; Bertoni F
    Blood; 2015 Mar; 125(12):1922-31. PubMed ID: 25612624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of mutations of the histone methyltransferase gene EZH2 in splenic b-cell marginal zone lymphoma.
    Salido M; Martinez-Avilés L; Ademà V; Ferrer A; Espinet B; Garcia M; Salar A; Besses C; Florensa L; Serrano S; Bellosillo B; Solé F
    Leuk Res; 2011 Mar; 35(3):e23-4. PubMed ID: 21087793
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.